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ABSTRACT: Three new thiosemicarbazones (TSCs) HL1−HL3
as triapine analogues bearing a redox-active phenolic moiety at the
terminal nitrogen atom were prepared. Reactions of HL1−HL3
with CuCl2·2H2O in anoxic methanol afforded three copper(II)
complexes, namely, Cu(HL1)Cl2 (1), [Cu(L
2)Cl] (2′), and
Cu(HL3)Cl2 (3), in good yields. Solution speciation studies
revealed that the metal-free ligands are stable as HL1−HL3 at pH
7.4, while being air-sensitive in the basic pH range. In dimethyl
sulfoxide they exist as a mixture of E and Z isomers. A mechanism
of the E/Z isomerization with an inversion at the nitrogen atom of
the Schiff base imine bond is proposed. The monocationic
complexes [Cu(L1−3)]+ are the most abundant species in aqueous
solutions at pH 7.4. Electrochemical and spectroelectrochemical
studies of 1, 2′, and 3 confirmed their redox activity in both the cathodic and the anodic region of potentials. The one-electron
reduction was identified as metal-centered by electron paramagnetic resonance spectroelectrochemistry. An electrochemical
oxidation pointed out the ligand-centered oxidation, while chemical oxidations of HL1 and HL2 as well as 1 and 2′ afforded several
two-electron and four-electron oxidation products, which were isolated and comprehensively characterized. Complexes 1 and 2′
showed an antiproliferative activity in Colo205 and Colo320 cancer cell lines with half-maximal inhibitory concentration values in
the low micromolar concentration range, while 3 with the most closely related ligand to triapine displayed the best selectivity for
cancer cells versus normal fibroblast cells (MRC-5). HL1 and 1 in the presence of 1,4-dithiothreitol are as potent inhibitors of mR2
ribonucleotide reductase as triapine.
■ INTRODUCTION
Thiosemicarbazones (TSCs) are known as biologically active
compounds with a broad spectrum of pharmacological
properties, including anticancer activity.1−4 These properties
can be modulated by coordination to physiologically relevant
metal ions.5,6 In addition, as versatile ligands, TSCs have
tunable electronic and steric properties, which may have a
favorable effect on their pharmacological profile.7−10 α-N-
Heterocyclic TSCs such as 2-formylpyridine TSC (FTSC) and
5-hydroxy-2-formylpyridine TSC were reported to possess
anticancer activity several decades ago,11,12 and further
optimization resulted in the most well-known TSC, 3-
aminopyridine-2-carboxaldehyde TSC (triapine). Triapine
was tested in more than 30 clinical phase I and II trials and
currently is involved in a triapine-cisplatin-radiation combina-
tion therapy in phase III trial.13 Because of the documented
side effects (e.g., methemoglobinemia) of triapine and its
unfavorable pharmacokinetic profile (e.g., short plasma half-
life),14 the development of novel TSCs with improved
pharmaceutical properties and an established mechanism of
action is of high research interest. Notably, two other TSCs,
namely, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemi-
carbazone (DpC) and 4-(2-pyridinyl)-2-(6,7-dihydro-8(5H)-
quinolinylidene)-hydrazide (COTI-2), are currently under-
going a phase I evaluation as chemotherapeutic agents.8,15
The iron-containing ribonucleotide reductase (RNR) is
considered as one of the main targets for triapine and related
α-N-pyridinecarboxaldehyde TSCs.16−19 This enzyme cata-
lyzes the reduction of ribonucleotides to deoxyribonucleotides,
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and it is particularly important in rapidly dividing cells, such as
tumor cells, virally infected cells, and invading bacteria. All
these cells share similar properties, such as high proliferation
rates, quickly spreading within the host, and aggressive disease
progression.20 A sustained proliferation requires an increased
de novo nucleotide synthesis for DNA replication, making
RNR targeting a relevant strategy in the treatment of
cancer.21,22 RNRs are free radical-containing proteins. One
way to control and modulate their reactivity is via quenching
the catalytically essential tyrosyl radical Y· located in the small
RNR subunit (R2 or NrdB).23,24 The radical scavengers and
iron-chelating ligands, which are able to destroy the diferric-
tyrosyl radical cofactor, with the aim to inhibit R2 RNR, are
widely investigated in anticancer research.25 In the case of
triapine, it has been suggested that the intracellularly formed,
highly potent, redox-active iron complex either leads to
reactive oxygen species (ROS) formation, which are then
responsible for tyrosyl radical quenching, or that the iron(II)
complex itself is able to directly reduce the tyrosyl radical.16
Besides triapine, several other R2 RNR inhibitors such as
hydroxyurea, 3,4-dihydroxybenzohydroxamic acid (Didox),
and 3,4,5-trihydroxybenzamidoxime (Trimidox) have entered
clinical trials.26 Among other potential tyrosyl radical
quenchers, p-alkoxyphenols (i.e., p-methoxyphenol, p-ethox-
yphenol, p-propoxyphenol, and p-allyloxyphenol) and pyro-
gallol as well as 4-mercaptophenol were identified.27−29 The
mechanism of RNR inhibition by the p-alkoxyphenols and
pyrogallol was investigated by both experimental techniques
(electron paramagnetic resonance (EPR) and UV−visible
(UV−vis) spectroscopy) and theoretical tools (molecular
docking and molecular dynamics simulations). Among the
aminophenols several compounds were tested as anticancer
agents, for example, the nonsteroidal anti-inflammatory drug
N-acetyl-p-aminophenol (acetaminophen), which showed
antimelanoma activity to prooxidant glutathione (GSH)
depletion by the 3-hydroxy-1,4-quinone-imine-metabolite.29,30
Fenretinide (a synthetic retinoid derivative) was introduced in
clinical trials for the treatment of breast, bladder, renal, and
neuroblastoma malignancies due to its antioxidant activities via
scavenging radicals.31
It is also worth noting that a coordination to copper(II) may
significantly augment the cytotoxic activity of TSCs.6,10
Copper(II) as an essential trace element is redox-active,
biocompatible, and less toxic than nonendogenous heavy
metals. The redox metabolism of cancer cells is different from
that of healthy cells and is characterized by increased copper
levels in an intracellular environment.32,33 Moreover, it was
recently suggested that the copper(II) TSC complexes, rather
than any metal-free TSCs or their cellular metabolites, are
responsible for the biological effects in vitro and in vivo.6 One
of the reasons for the increased antiproliferative activity of
copper(II) complexes of TSCs and the selectivity for cancer
cells is considered to be the redox cycling between two
oxidation states (Cu2+ ↔ Cu+) in a biologically accessible
window of potentials (from −0.4 to +0.8 V vs normal
hydrogen electrode (NHE)) and ROS generation.6,34 In this
context it is also remarkable that a copper-redox cycle
mechanism was found to be responsible for the oxidation of
phenolic compounds leading ultimately to reactive oxygen-
dependent DNA damage.35 The same authors suggested that
singlet oxygen or a singlet oxygen-like entity (e.g., a copper-
peroxide complex) rather than the free hydroxyl radical plays a
role in DNA damage.35 At the same time it is worth noting that
the idea that an efficient redox cycling of copper(II,I)
complexes with thiosemicarbazones can be involved in the
anticancer mechanism has been recently challenged36 by
showing that the most resistant to reduction copper(II)
thiosemicarbazonates were the most cytotoxic. In addition, the
complexes can also dissociate fast, if the thiosemicarbazone has
different affinities to copper(II) and copper(I) and can lose the
competition for copper(I) to metallothioneins (MT) and
glutathione (GSH).37
With this background in mind we aimed at (i) attachment of
a phenolic moiety at atom N4 of thiosemicarbazide, (ii)
investigation of solution speciation, complex formation
reactions of new TSCs with copper(II) in solution, and
synthesis of copper(II) complexes, (iii) investigation of the
reduction/oxidation of TSCs containing this potentially redox
active group, namely, the 4-aminophenolic unit, and copper-
(II) complexes thereof by electrochemical and spectroelec-
trochemical techniques and by using chemical oxidants, for
example, O2, p-benzoquinone (PBQ), 2,3-dichloro-5,6-dicya-
no-1,4-benzoquinone (DDQ), and phenyliodine(III) diacetate
(PIDA), as two-electron/two proton acceptors and Ag2O,
along with an analysis of the reversibility of the oxidation
process and the number of participating electrons, (iv)
identification of the effects of phenolic unit and coordination
to copper(II) on the redox activity and cytotoxicity in vitro as
well as on the mR2 RNR inhibition and estimation of their
potency to act as reductants for a tyrosyl radical with an
apparent redox potential of +1000 ± 100 mV versus NHE.38
In this work we report on the synthesis of new triapine
derivatives HL1−HL3, which contain a potentially redox-active
4-aminophenolic unit, and of copper(II) complexes Cu(HL1)-
Cl2 (1), [Cu(L
2)Cl] (2′), and Cu(HL3)Cl2 (3) (Chart 1).
The solution behavior of the new TSCs (HL1−HL3), the
mechanism typical for TSC E/Z isomerization, and the
stability and redox properties of both the metal-free ligands
and copper(II) complexes (1, 2′, 3) were also investigated by
UV−vis spectrophotometry and UV−vis/EPR spectroelectro-
chemistry and density functional theory (DFT) calculations. In
addition, the two- and four-electron oxidation products HL1a′
and HL1a″, respectively, were prepared both electrochemically
Chart 1. TSCs and Their Copper(II) Complexes Studied in
This Worka
aUnderlined labels/numbers indicate compounds studied by SC-
XRD. The five-coordination of copper(II) in 1 and 3 has not been
confirmed by X-ray crystallography.
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and by chemical oxidation and used in a complex formation
with copper(II). Several oxidation products of HL2 (HL2b,
HL2e, HL2c′, and HL2c″) were prepared by using different
oxidation agents. Likewise, copper(II) complexes with oxidized
ligands 4−6 were obtained (see Chart 2 and Scheme 1). The
isolated compounds were characterized by analytical and
spectroscopic methods (one-dimensional (1D) and two-
dimensional (2D) NMR, UV−vis, IR), electrospray ionization
(ESI) mass spectrometry (MS), cyclic voltammetry (CV), and
single-crystal X-ray diffraction (SC-XRD). The anticancer
activity of the TSCs (HL1−HL3), their oxidized products
(HL1a′, HL1a″, and HL2c′·CH3COOH), and the copper(II)
complexes (1, 2′, and 3) was tested against two human cancer
cell lines (doxorubicin-sensitive Colo205 and the multidrug-
resistant Colo320 human colonic adenocarcinoma) and
normal human embryonal lung fibroblast cells (MRC-5)
along with their mR2 RNR inhibiting ability, and the results
are discussed.
■ EXPERIMENTAL SECTION
Chemicals. 2-Formylpyridine, 2-acetylpyridine, and CuCl2·2H2O
were purchased from commercial suppliers and used without further
purification. 3-(tert-Butoxycarbonyl)amino-2-formylpyridine and 4-
(4-hydroxy-3,5-dimethylphenyl)thiosemicarbazide were synthesized
as reported previously.39,40 KCl, KOH, HCl, and dimethyl sulfoxide
(DMSO) were obtained from Reanal. GSH, 2-morpholinoethane-
sulfonic acid (MES), and 2-[4-(2-hydroxyethyl)piperazin-1-yl]-
ethanesulfonic acid (HEPES) were purchased from Sigma-Aldrich
and used without further purification. Copper(II) stock solution was
prepared by the dissolution of CuCl2 in water, and its concentration
was determined by complexometry with ethylenediaminetetraacetic
acid (EDTA). The stock solutions of HL1−HL3 in DMSO were
prepared on a weight-in-volume basis.
2-Formylpyridine 4-(4-hydroxy-3,5-dimethylphenyl)-
thiosemicarbazone (HL1·0.5H2O). 2-Formylpyridine (0.09 mL,
0.95 mmol) was added to 4-(4-hydroxy-3,5-dimethylphenyl)-
thiosemicarbazide (200 mg, 0.95 mmol) in ethanol (12 mL), heated
at 85 °C for 2 h, concentrated, and left for crystallization at 4 °C. The
Chart 2. Oxidation Products of HL1 and HL2 and Copper(II) Complexes with Oxidized Ligandsa
aUnderlined labels/numbers indicate compounds studied by SC-XRD, while the italic L denotes an oxidized ligand.
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yellow solid was filtered off, washed with cold ethanol, and dried in
vacuo. Yield: 253 mg, 86.1%. Anal. Calcd for C15H16N4OS·0.5H2O
(Mr = 309.39): C, 58.23; H, 5.54.; N, 18.11; S, 10.36; Found: C,
57.91; H, 5.45; N, 17.92; S, 10.43%. Positive ion ESI-MS for
C15H16N4OS (MeCN/MeOH+1% H2O): m/z 301.11 [HL
1+H]+,
323.09 [HL1+Na]+, 339.07 [HL1+K]+, negative ion ESI-MS: m/z
299.10 [HL1−H]−. 1H NMR (600 MHz, DMSO-d6, E isomer) δ,
ppm: 11.86 (s, 1H, H9), 10.00 (s, 1H, H11), 8.57 (d, J = 4.4 Hz, 1H,
H6), 8.43 (d, J = 8.0 Hz, 1H, H3), 8.22 (s, 1H, H18), 8.16 (s, 1H, H7),
7.82 (td, J = 7.8, 1.2 Hz, 1H, H4), 7.37 (m, 1H, H5), 7.02 (s, 2H,
H13+H17), 2.17 (s, 6H, H19+H20).
13C NMR (151 MHz, DMSO-d6, E
isomer) δ, ppm: 176.55 (C10), 153.31 (C2), 151.10 (C15), 149.27
(C6), 142.51 (C7), 136.43 (C4), 130.18 (C12), 126.26 (C13+C17),
124.10 (C5), 123.84 (C14+C16), 120.54 (C3), 16.62 (C19+C20).
15N
NMR (61 MHz, DMSO-d6, E isomer) δ, ppm: 325.04 (N8), 315.07
(N1), 174.22 (N9), 128.93 (N11). IR (attenuated total reflectance
(ATR), selected bands, ṽmax): 3107.39, 2950.74, 1531.05, 1477.88,
1428.74, 1201.82, 1105.17, 926.54, 862.73, 761.37, 682.25 cm−1.
UV−vis (MeOH), λmax, nm (ε, M−1 cm−1): 243 sh, 328 (3516).
Single crystals of HL1·C2H5OH suitable for X-ray data collection were
obtained from the mother liquor.
2-Acetylpyridine 4-(4-hydroxy-3,5-dimethylphenyl)-
thiosemicarbazone (HL2·0.2H2O). 2-Acetylpyridine (0.21 mL,
1.91 mmol) was added to 4-(4-hydroxy-3,5-dimethylphenyl)-
thiosemicarbazide (269 mg; 1.27 mmol) in ethanol (8 mL), heated
at 85 °C overnight, concentrated, and left for crystallization at 4 °C.
The obtained light yellow precipitate was filtered off, washed with
cold ethanol, and dried in vacuo. Yield: 271 mg, 67.0%. Anal. Calcd
for C16H18N4OS·0.2H2O (Mr = 318.01): C, 60.43; H, 5.83; N, 17.62;
S, 10.08. Found: C, 60.47; H, 5.8; N, 17.55; S, 10.13%. Positive ion
ESI-MS for C16H18N4OS (Mr = 314.41) (MeCN/MeOH+1% H2O):
m/z 315.13 [HL2+H]+, 337.11 [HL2+Na]+, negative ion ESI-MS: m/
Scheme 1. Oxidation Products of HL1 and HL2 along with Those of Copper(II) Complexesa
aThe bottom left panel shows the oxidants used.
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z 313.11 [HL2−H]−. 1H NMR (600 MHz, DMSO-d6, E isomer) δ,
ppm: 10.46 (s, 1H, H9), 9.94 (s, 1H, H11), 8.59 (d, J = 4.7 Hz, 1H,
H6), 8.54 (d, J = 8.1 Hz, 1H, H3), 8.22 (s, 1H, H18), 7.79 (td, J = 7.8,
1.7 Hz, 1H, H4), 7.39 (dd, J = 7.2, 4.9 Hz, 1H, H5), 7.02 (s, 2H,
H13+H17), 2.44 (s, 3H, H7′), 2.17 (s, 6H, H19+H20).
13C NMR (151
MHz, DMSO-d6, E isomer) δ, ppm: 177.36 (C10), 154.59 (C2),
151.12 (C15), 148.54 (C7), 148.43 (C6), 136.34 (C4), 130.36 (C12),
126.33 (C13+C17), 124.00 (C5), 123.83 (C14+C16), 121.18 (C3),
16.63 (C19+C20), 12.31 (C7′).
15N NMR (61 MHz, DMSO-d6, E
isomer) δ, ppm: 312.94 (N8), 310.61 (N1), 168.53 (N9), 129.34
(N11). IR (ATR, selected bands, ṽmax): 3386.87, 3187.76, 1531.57,
1478.45, 1309.19, 1182.40, 1032.57, 942.48, 778.97, 652.93 cm−1.
UV−vis (MeOH), λmax, nm (ε, M−1 cm−1): 316 (2842), 407 sh.
Single crystals of HL2 suitable for X-ray data collection were obtained
from the mother liquor.
3 -Am ino - 2 - f o rmy l p y r i d i n e 4 - ( 4 - h yd roxy - 3 , 5 -
dimethylphenyl)thiosemicarbazone (HL3·0.25H2O). To a sol-
ution of 3-(tert-butoxycarbonyl)amino-2-formylpyridine (210 mg,
0.95 mmol) and 4-(4-hydroxy-3,5-dimethylphenyl)thiosemicarbazide
(200 mg, 0.95 mmol) in a mixture of ethanol/water 3:1 (8 mL) was
added dropwise 12 M HCl (0.19 mL, 2.28 mmol). This solution was
stirred at room temperature for 1 h to give Boc-HL3·HCl
(C20H25N5O3S·HCl, positive ion ESI-MS for C20H25N5O3S (Mr =
415.51) (MeCN/MeOH+1% H2O): m/z 416.18 [Boc-HL
3+H]+,
negative ion ESI-MS: m/z 414.02 [Boc-HL3−H]−). The Boc-
deprotection of HL3 was completed at 85 °C for 7 h with monitoring
by ESI-MS (positive ion ESI-MS for C15H17N5OS (Mr = 315.39)
(MeCN/MeOH + 1% H2O): m/z 316.12 [HL
3+H]+, 338.11
[HL3+Na]+, negative ion ESI-MS: m/z 314.11 [HL3−H]−). After
ethanol evaporation, the solution was neutralized with a saturated
solution of NaHCO3 (pH = 8). The precipitate was collected and
dried in vacuo. Yield: 267 mg, 87.9%. Anal. Calcd for C15H17N5OS·
0.25H2O (Mr = 319.90): C, 56.31; H, 5.51; N, 21.89; S, 10.02.
Found: C, 56.33; H, 5.34; N, 21.68; S, 10.29%. 1H NMR (600 MHz,
DMSO-d6, E isomer) δ, ppm: 11.47 (s, 1H, H9), 9.70 (s, 1H, H11),
8.39 (s, 1H, H7), 8.21 (s, 1H, H18), 7.85 (dd, J = 4.3, 1.4 Hz, 1H, H6),
7.15 (dd, J = 8.3, 1.2 Hz, 1H, H4), 7.08 (dd, J = 8.3, 4.3 Hz, 1H, H5),
6.92 (s, 2H, H13+H17), 6.49 (s, 2H, H3′), 2.16 (s, 6H, H19+H20).
13C
NMR (151 MHz, DMSO-d6, E isomer) δ, ppm: 176.13 (C10), 151.17
(C15), 149.23 (C7), 143.99 (C3), 137.25 (C6), 132.97 (C2), 130.59
(C12), 126.88 (C13+C17), 124.52 (C5), 123.83 (C14+C16), 122.34
(C4), 16.63 (C19+C20).
15N NMR (61 MHz, DMSO-d6, E isomer) δ,
ppm: 321.53 (N1), 312.8 (N8), 174.57 (N9), 126.69 (N11), 71.10
(N3′). IR (ATR, selected bands, ṽmax): 3456.59, 3347.73, 3142.99,
3002.80, 1615.50, 1547.68, 1512.07, 1299.63, 1248.47, 1189.77,
1143.84, 861.56, 796.22, 685.36 cm−1. UV−vis (MeOH), λmax, nm (ε,
M−1 cm−1): 299 (1374), 375 (2220), 448 sh. Single crystals of HL3
suitable for X-ray data collection were obtained from the mother
liquor.
■ SYNTHESIS OF THE COPPER(II) COMPLEXES
Cu(HL1)Cl2·0.5H2O (1·0.5H2O). CuCl2·2H2O (128 mg,
0.75 mmol) was added to HL1 (225 mg, 0.75 mmol) in anoxic
methanol (10 mL) in a Schlenk tube and stirred at room
temperature under argon for 10 min. The reaction mixture was
allowed to stand at 4 °C overnight. The dark green precipitate
was filtered off under argon, washed with anoxic methanol, and
dried in vacuo. Yield: 294 mg, 88.4%. Anal. Calcd for
C15H16N4OSCuCl2·0.5H2O (Mr = 443.84): C, 40.59; H,
3.86; N, 12.62; S, 7.22. Found: C, 40.73; H, 3.59; N, 12.63; S,
7.19%. Positive ion ESI-MS for C15H16N4OSCuCl2 (MeCN/
MeOH+1% H2O): m/z 362.03 [Cu(HL
1)2+−H]+, negative ion
ESI-MS: m/z 395.99 [Cu(HL1)Cl+−2H]−. IR (ATR, selected
bands, ṽmax): 3480.77, 2989.07, 1610.63, 1479.59, 1269.25,
1229.98, 1189.75, 1025.69, 774.69, 665.85 cm−1. UV−vis
(MeOH), λmax, nm (ε, M
−1 cm−1): 280 (16 800), 376 sh, 422
(18 160). Crystals of [Cu(L1)Cl]·CH3OH (1′·CH3OH) (Mr =
398.37) suitable for X-ray diffraction study were grown from
an ∼20-fold-diluted reaction mixture in a Schlenk tube under
argon upon standing at 4 °C. A recrystallization of [Cu(HL1)-
Cl2] (1) in methanol in air afforded a minor amount of X-ray
diffraction-quality crystals of [Cu(L1c′)Cl] (4).
[Cu(L2)Cl]·0.5H2O (2′·0.5H2O). CuCl2·2H2O (129 mg,
0.76 mmol) was added to a solution of HL2 (238 mg, 0.76
mmol) in anoxic methanol (10 mL) in a Schlenk tube. The
reaction mixture was stirred at room temperature under argon
for 10 min and then allowed to stand at 4 °C overnight. The
greenish-brown precipitate was filtered off under argon,
washed with anoxic methanol, and dried in vacuo. Yield: 316
mg, 98.8%. Anal. Calcd for C16H17N4OSCuCl·0.5H2O (Mr =
421.40): C, 45.60; H, 4.31; N, 13.30; S, 7.61. Found: C, 45.74;
H, 4.03; N, 13.42; S, 7.56%. Positive ion ESI-MS for
C16H17N4OSCuCl (MeCN/MeOH+1% H2O): m/z 376.04
[Cu(L2)]+, negative ion ESI-MS: m/z 410.00 [Cu(L2)Cl−H]−.
IR (ATR, selected bands, ṽmax): 3341.84, 3223.12, 1609.18,
1547.35, 1483.22, 1452.56, 1303.41, 1202.82, 1019.61, 846.14,
701.29 cm−1. UV−vis (MeOH), λmax, nm (ε, M−1 cm−1): 277
(11 835), 316 sh, 421 (12 953). Crystals of [Cu(L2)Cl] (2′)
suitable for X-ray diffraction study were obtained from an ∼20-
fold-diluted reaction mixture under argon in a Schlenk tube at
4 °C.
Cu(HL3)Cl2·0.25H2O (3·0.25H2O). CuCl2·2H2O (114 mg,
0.67 mmol) was added to HL3 (210 mg, 0.67 mmol) in anoxic
methanol (10 mL) in a Schlenk tube and stirred at room
temperature under argon for 10 min. The reaction mixture was
allowed to stand at 4 °C overnight. The green precipitate was
filtered off under argon, washed with anoxic methanol, and
dried in vacuo. Yield: 285 mg, 93.6%. Anal. Calcd for
C15H17N5OSCuCl2·0.25H2O (Mr = 454.35): C, 39.65; H,
3.88; N, 15.41; S, 7.06. Found: C, 39.58; H, 3.79; N, 15.21; S,
6.98%. Positive ion ESI-MS for C15H17N5OSCuCl2 (MeCN/
MeOH+1% H2O): m/z 377.04 [Cu(HL
3)2+−H]+, negative ion
ESI-MS: m/z 411.00 [Cu(HL3)Cl+−2H]−. IR (ATR, selected
bands, ṽmax): 3422.07, 3340.63, 1647.85, 1569.29, 1480.67,
1223.63, 1185.74, 1023.07, 718.76, 660.61 cm−1. UV−vis
(MeOH), λmax, nm (ε, M
−1 cm−1): 262 (19 564), 288
(17 425), 462 (23 514). Crystals of [Cu(L3)Cl]·CH3OH,
(3′·CH3OH) (Mr = 413.38) suitable for X-ray diffraction study
were grown from an ∼20-fold-diluted reaction mixture in a
Schlenk tube under argon at 4 °C.
Details about the synthesis and characterization of oxidized
thiosemicarbazones and their copper(II) complexes, X-ray data
collection and refinement (Tables S1−S3), elemental analysis,
UV−vis titrations, kinetic measurements, lipophilicity deter-
mination, spectroelectrochemical studies, in vitro cell studies,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT) assays, and tyrosyl radical reduction in mouse R2 RNR
protein as well as computational details are given in the
Supporting Information (Sections 1 and 2).
■ RESULTS AND DISCUSSION
Synthesis and Characterization of HL1−HL3. The new
TSCs HL1−HL3 were obtained by Schiff base condensation
reac t ions o f 4 - (4 -hydroxy -3 ,5 -d imethy lpheny l) -
thiosemicarbazide40 with the corresponding aldehyde (HL1,
HL3) or ketone (HL2) in boiling ethanol (HL1, HL2) or
ethanol/water (3:1, HL3) in the absence (HL1 and HL2) or in
the presence of 12 M HCl (HL3). The hydrochloric acid in
this latter case was used for Boc-deprotection of the
intermediate Boc-HL3. This deprotection reaction was
monitored by ESI-MS (disappearance of peaks attributed to
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[Boc-HL3+H]+ and [Boc-HL3−H]− ions) and completed at 85
°C after 7 h, with yields ranging from 67 to 88%. The
formation of HL1−HL3 was confirmed by ESI mass spectra,
which showed peaks assigned to ions [HL1−3+H]+,
[HL1−3+Na]+, and [HL1−3−H]−. One- and two-dimensional
NMR spectra were in agreement with the expected structures
for HL1−HL3 of C1 molecular symmetry. In addition, the
spectra indicated the presence of E and Z isomers in DMSO-
d6, which is typical for thiosemicarbazones,
41−43 with a
significant predominance of E isomers (E/Z = 23:1, 17:1,
and 31:1 for HL1−HL3, respectively). The assignment of E
and Z isomers was based on NMR spectra, including 1H, 1H
nuclear Overhauser effect spectroscopy (NOESY), which are
presented in more detail in the Supporting Information (see
also Schemes S1 and S2 and Tables S4−S6). It is noteworthy
that, in contrast to the E isomers of HL1−HL3, their Z isomers
can form an intramolecular hydrogen bond between the
pyridine nitrogen and the NH-N group hydrogen, resulting in
an increase in the relative stability of these conformers. Indeed,
the DFT B3LYP/6-311++G (d,p) calculations for E- and Z-
HL1 in a DMSO solution (the polarizable continuum model
(PCM) solvation model) showed that the most stable
conformer of Z-HL1 lies lower in energy than the most stable
conformer of E-HL1 (ΔE = 1.45 kcal/mol; ΔG = 0.76 kcal/
mol at 298 K and 1 atm). The calculations also demonstrate
that E- and Z-HL2 are very close in thermodynamic stability
(ΔE = 0.90 kcal/mol in favor of Z-HL2, ΔG = 0.00 kcal/mol),
and E-HL3 is slightly more stable than Z-HL3 (ΔE = 0.84 kcal/
mol, ΔG = 0.86 kcal/mol), which can be explained by the
presence of an intramolecular hydrogen bond between the 3-
NH2 group and the aldimine nitrogen in E-HL
3. Thus, the
formation of HL1−HL3 with a large predominance of the E
isomers indicates that the reactions proceed under a kinetic
control. By using DFT B3LYP/6-311++G(d,p) calculations to
understand the interconversion between E and Z isomers of 2-
formylpyridine and thiosemicarbazones as model compounds
we found out that an isomerization involving a tautomeric shift
of the thioamide N2H proton to the pyridine nitrogen
followed by a rotation around the formed C−N1 bond, as
proposed previously,44 is not favored energetically (see the
Supporting Information for details). We believe that the most
plausible Z/E isomerization pathway in thiosemicarbazones
and semicarbazones involves an inversion at the imine
nitrogen.45 The intrinsic reaction coordinate (IRC) analysis
for one of the aforementioned model compounds revealed that
the found transition state connects the desired minima.
However, the calculation data obtained show (for more details
see the Supporting Information) that the Gibbs free energy
barrier for the conversion of the most stable conformer of the
Z isomer into the E isomer is relatively high (ΔG = 35.2 kcal/
mol in the gas phase, 35.4 kcal/mol in DMSO solution)
(Figure 1), which rejects the possibility of an interconversion
between the isomers at room temperature.
The redox activity of HL1−HL3 in the anodic region was
validated by cyclic voltammetry (vide infra). Their behavior as
reductants is also relevant for quenching the tyrosyl radical in
the mR2-protein. Therefore, attempts to perform an oxidation
of HL1 and HL2 by electrolysis and by chemical oxidation were
undertaken.
Oxidation of TSCs. The oxidation of different organic
molecules with p-benzoquinone derivatives is well-documented
in the literature.46 The reaction of HL1 with DDQ (2e−/2H+
E° = +0.887 V vs NHE in an acidic 0.1 M aqueous solution of
p-TsOH)47 in a 1:1 molar ratio resulted in two-electron and
four-electron oxidative cyclizations with the major formation of
HL1a′ (60.9%) accompanied by a minor generation of HL1a″
(<5%), both containing a 1,3,4-thiadiazole ring (Chart 2,
Scheme 1). The formation of the 1,3,4-thiadiazole ring occurs
via a nucleophilic attack of the sulfur atom to the carbon atom
of the aldimine bond of HL1 as evidenced by frontier
molecular orbitals with the highest occupied molecular orbital
(HOMO) and lowest unoccupied molecular orbital (LUMO)
located at opposite sides of the molecule (Figure 2).
The use of a double amount of DDQ led to the formation of
the four-electron oxidation product HL1a″ in 71.6% yield. The
electrolysis of HL1 at 1000 mV in CH3CN versus Ag/AgCl
resulted in the same oxidation products (vide infra). Both
compounds were characterized by ESI mass spectra, which
showed peaks at m/z 299.17 [HL1a′+H]+, 321.16
[HL1a′+Na]+, 297.18 [HL1a″+H]+, 319.20 [HL1a″+Na]+, and
296.94 [HL1a′−H]−. The more sterically hindered ketimine
carbon atom in HL2 was expected to reduce the likelihood of
Figure 1. Electronic energy and Gibbs free energy profiles (in kcal/mol) for the transformation of the most stable conformer of (Z)-2-
formylpyridine thiosemicarbazone into the most stable conformer of (E)-2-formylpyridine thiosemicarbazone in DMSO solution. Free energies (in
parentheses) at 298 K and 1 atm.
Inorganic Chemistry pubs.acs.org/IC Article
https://doi.org/10.1021/acs.inorgchem.1c01275
Inorg. Chem. XXXX, XXX, XXX−XXX
F
the 1,3,4-thiadiazole ring formation. The reaction of HL2 with
DDQ in a 1:1 molar ratio in methanol led to decomposition of
the TSC with formation of an unidentified species. When PBQ,
a weaker oxidant (2e−/2H+ E° = 0.643 V vs NHE in an acidic
0.1 M aqueous solution of p-TsOH) than DDQ, was used,47 a
two-electron oxidative cyclization with the formation of a
1,2,4-triazole-3-thione ring (TAT group, HL2b) occurred,
accompanied by desulfurization of HL2 and conversion into
diphenolic species HL2e (DP group).48 The formation of HL2b
was confirmed by ESI mass spectra, where peaks correspond-
ing to [HL2b+H]+ (m/z 313.25), [HL2b+Na]+ (m/z 335.14),
and [HL2b−H]− (m/z 310.99) were present. We suppose that
the initial step of the reaction of HL2 with PBQ involves a one-
electron oxidation of HL2 favored by the character of the
HOMO of HL2 (see Figure S1) along with a NH
deprotonation to give a highly conjugated N/S-centered free
radical (see Scheme S8 in Supporting Information). This
radical intermediate transforms into triazole HL2b in two steps
or undergoes a fragmentation affording 4-isothiocyanato-2,6-
dimethylphenol. The phenol reacts with HL2 via an SE2
mechanism to form the corresponding thioamide followed by a
radical-promoted intermolecular transformation into indole
HL2e according to a Fukuyama-like indole synthesis49 (for a
more detailed discussion of the oxidation of HL2 with PBQ see
the Supporting Information).
Other oxidation agents (lead tetraacetate, phenyliodine(III)
diacetate (PIDA) with E° = +1.70 V vs Fc/Fc+ in ACN,50 and
silver(I) oxide) for N-alkyl(aryl)-aminocarbonyl-4-aminophe-
nols,51 were also used in an attempt to obtain the desired
oxidation products with a 1,4-benzoquinone imine moiety (see
also Scheme S3, its accompanying explanation, and Figure S2
in the Supporting Information). The exposure of HL2 to 1
equiv of PIDA furnished the two-electron oxidized product
HL2c′ and traces of the four-electron oxidized species HL2c″.
As for HL1a′ and HL1a″, the use of a double amount of oxidant
resulted in HL2c″ as the main oxidation product. ESI mass
spectra showed peaks at m/z 313.21, 310.98 attributed to
[HL2c′+H]+, [HL2c′−H]− as well as 311.12, 309.01 assigned to
[HL2c″+H]+, HL2c″−H]− in line with the loss of two (HL2c′)
or four (HL2c″) protons when compared to original TSC HL2
(315.13 [HL2+H]+, 313.11 [HL2−H]−).
Characterization of Oxidized Organic Compounds by
NMR Spectroscopy. The formation of a 1,3,4-thiadiazole-
ring in HL1a′ and HL1a″ by an oxidation of HL1 resulted in the
disappearance of peaks of the aldimine CH proton (H7) and
NH (H9) in HL
1a′ and HL1a″ as well as of the signal of NH
(H11) in HL
1a″. The formation of a 1,4-benzoquinone imine
moiety in HL1a″ was confirmed also by the absence of the OH
signal, which resonates at 8.08−8.22 ppm in HL1−HL3, HL1a′
(see Scheme S4 and Tables S4−S6 in the Supporting
Information). The ring-closure reaction resulted in a downfield
shift of the resonance signal of carbon C7, which was directly
involved in the 1,3,4-thiadiazole ring formation. The
quaternary carbon C7 in HL
1a′ and HL1a″ resonates at
158.40 and 169.98 ppm, respectively, whereas the aldimine CH
carbon atom C7 in HL
1 resonates at 142.51 ppm. Analogously,
the involvement of the sulfur atom in the 1,3,4-thiadiazole ring
led to a downfield shift of the signal of the carbon atom C10
(CS) to 166.77 ppm in HL1a′ and to 171.58 ppm in HL1a″
when compared to 176.55 ppm in HL1.
The four-electron oxidation of HL1 to HL1a″ with the
formation of the imine N(11)C(12) bond resulted in strong
downfield shift of the resonance signal of carbon C12 of 1,4-
benzoquinone moiety of HL1a″ (162.21 ppm) when compared
to that of carbon C12 of phenolic moiety in HL
1−HL3, HL1a′
(130.18−132.53 ppm). In addition, the formation of the
carbonyl C(15)O(18) bond in HL1a″ has a strong effect on
the resonance of carbon atom C15, which is strongly downfield-
shifted to 187.14 ppm when compared to that in HL1−HL3
and HL1a′ at 148.97−151.17 ppm. Remarkable shifts of
resonance signals for other atoms of the 1,4-benzoquinone
moiety in HL1a″ in comparison to the phenolic moiety in
HL1−HL3 and HL1a′ were also noticed (see the Supporting
Information and Scheme S5 therein).
The formation of the benzothiazole ring in HL2c′ is
evidenced by the presence in the 1H NMR spectrum of one
singlet of the CH group and two singlets of methyl groups of
an unsymmetrical phenolic moiety with the intensity ratio of
1:3:3 as well as by one NH signal at 11.76 ppm in comparison
with a number of signals in the spectrum of HL2 (1(NH)/
1(NH)/2(CH)/6(CH3)). Of the two proposed tautomers for
HL2c′ (A (N(11)H) and B (N(9)H); see Scheme S6 in the
Supporting Information) the formation of the E isomer of form
B in DMSO-d6 was evidenced by the cross-peak between
protons of methyl (H7′) and NH (H9) groups in the
1H, 1H
NOESY spectrum. The DFT B3LYP/6-311++G(d,p) calcu-
lations showed that the E isomer of tautomer A is less stable
than the E isomer of tautomer B in a DMSO solution (ΔE =
1.58 kcal/mol; ΔG = 1.01 kcal/mol at 298 K and 1 atm). We
found that, in contrast to HL1−HL3, the E/Z isomerization
was observed for HL2c′. As expected in case of HL2c′·
CH3COOH, where nitrogen atom N1 of the pyridine ring is
protonated and prevents the hydrogen-bond formation
between H9 and N1, which is present in the Z isomer of
HL2c′, only one set of signals attributed to the E isomer was
found. The neutral species HL2c′ in DMSO-d6 and MeOH-d4
is present as the E isomer, which converts slowly into the Z
isomer. The process is solvent-dependent. The E/Z equili-
brium was reached in 6 d with a molar ratio of E/Z isomers of
7.2:1 (DMSO-d6) and 3:1 (MeOH-d4) (see Figure S3 in the
Supporting Information). The Z isomer of HL2c′ in DMSO-d6
is characterized by the downfield-shifted proton NH(9) due to
Figure 2. Frontier orbitals in HL1: (a) LUMO and (b) HOMO
drawn at 0.1 au isosurface.
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the hydrogen bond to the pyridine nitrogen atom and
resonates at 15.00 ppm (the same proton of the E isomer of
HL2c′ is seen at 11.58 ppm). The Z/E isomerization of HL2c′
was also studied in MeOH-d4 and methanol by
1H NMR and
UV−vis spectroscopy reaching 1:3.6 molar ratio in 14 d
according to NMR spectra (for optical spectra difference see
Figure S4). The carbon atom of the methyl group (C7′) in the
E isomers of HL2c′·CH3COOH and HL2c′ resonates at 12.55
and 12.56 ppm, respectively, whereas in the Z isomer of HL2c′
it resonates at 21.72 ppm. Note that these chemical shifts are
consistent with those calculated for E- and Z-HL2c′ (8.29 and
23.26 ppm, respectively) by the gauge-independent atomic
orbital (GIAO) method at the WC04/6-311+G(2d,p) level of
theory using the DFT B3LYP/6-311++G(d,p) optimized
geometries (DMSO solution, the PCM solvation model). A
similar difference in chemical shifts of the CH3 group was also
observed for the E (12.31 ppm) and Z isomers (21.73 ppm) of
HL2. The DFT calculation also demonstrated that E and Z
isomers of HL2c′ have a quite similar stability in a DMSO
solution (ΔG = 0.11 kcal/mol in favor of the E isomer; 298 K,
1 atm). As expected, the pyridine ring carbon atom C3 is also
sensitive to the hydrogen-bond formation between H9 and N1
in the Z isomer of HL2c′. The C3 signal in the latter is
markedly shifted (124.08 ppm) in comparison to C3 in the E
isomer (119.65 ppm). A full assignment of resonances was
possible only for HL2c′·CH3COOH (the three quaternary
carbons C12, C7, and C17 were identified according to
1H, 13C
HMBC; see Figure S5 in the Supporting Information).
The two-electron oxidation of HL2c′ to HL2c″with the
formation of the quinone moiety is accompanied by the
downfield shift of the resonance signal of carbon C15 at 184.43
ppm in comparison to that of C15 in HL
2c′·CH3COOH at
148.14 ppm, in E-HL2c′ at 148.15 ppm, and in Z-HL2c′ at
148.39 ppm. The lack of the NH signal confirms the formation
of the imine N(9)C(10) bond (see Scheme S7 and Tables
S4 and S5 in the Supporting Information).
Synthesis and Characterization of Copper(II) Com-
plexes. The reaction of HL1−HL3 with CuCl2·2H2O in
anoxic methanol under an argon atmosphere to preclude an
eventual oxidation of the ligands by air oxygen in a 1:1 molar
ratio at room temperature afforded green-brown solids of the
formulas Cu(HL1)Cl2 (1), [Cu(L
2)Cl] (2′), and Cu(HL3)Cl2
(3) in almost quantitative yields. The formation of these
copper(II) complexes was confirmed by elemental analyses
and ESI mass spectra. The latter showed peaks attributed to
[Cu(L1,3)−H]+, [Cu(L1,3)Cl−H]−, or [Cu(L2)]+ and [Cu-
(L2)Cl−H]−. XRD-quality single crystals of [Cu(L1−3)Cl]
(1′−3′) were grown from diluted by a factor of ca. 20 reaction
mixtures under argon upon standing at 4 °C. Under these
conditions the deprotonation of ligands HL1 and HL3
occurred. Attempts to crystallize 1, 2′, and 3 in air failed,
most likely because of an occurring oxidation of complexes by
O2.
Synthesis of the Copper(II) Complexes with Oxidized
Ligands. Upon a prolonged standing of a methanolic solution
of Cu(HL1)Cl2 (1) in air, a minor amount of crystals of
[Cu(L1c′)Cl] (4) formed, in which the ligand underwent an
oxidative dehydrogenation along with the intramolecular
cyclization via a C−S coupling reaction between phenolic
carbon and thione group into a five-membered thiazole ring, as
confirmed by SC-XRD (vide infra). Some rare examples of
thiosemicarbazone cyclization with the benzothiazole ring
formation due to a coordination to copper(II) were recently
reported.52,53 A direct complex formation reaction between the
prepared benzo[d]thiazol-6-ol HL2c′ and copper(II) chloride
produced [Cu(HL2c′)Cl2] (6) under an inert atmosphere. The
same reaction in air was accompanied by a further oxidation of
HL2c′ with the formation of benzo[d]thiazol-6-one (HL2c″)
bound to copper(II). Complex 6 was characterized by the
positive ion ESI mass spectrum with a peak at m/z 374.08
attributed to [Cu(L2c′)]+, whereas the product obtained by an
oxidation in air revealed a peak at m/z 373.06 assigned to
[CuI(HL2c″)]+. The peak at m/z 373.06 was also seen when
the reaction mixture of HL2c″ with CuCl2·2H2O was subjected
to an ESI MS measurement.
The reactions of copper(II) with the oxidized TSCs, namely,
1,3,4-thiadiazole-containing species HL1a′ and HL1a″, were
monitored by ESI-MS experiments. When CuCl2·2H2O was
allowed to react with HL1a′ and HL1a″ in a 1:1 molar ratio, ESI
mass spectra of the reaction mixtures indicated the formation
of complexes with metal-to-ligand stoichiometry of 1:2,
namely, [Cu(HL1a′)2]+ and [Cu(HL1a″)2]+, respectively.
Interestingly, under varied reaction conditions (different
solvents, air atmosphere, and varied temperature and reaction
time, see details in Table S7) the synthesis of copper(II)
complex of HL1a′ resulted in a sequential oxidation of the two
ligands, and several oxidized products could be identified based
on ESI-MS peaks as [Cu(HL1a′)2]+ (m/z 659.16), [Cu-
(HL1a′)(HL1a″)]+ (m/z 657.13), [Cu(HL1a″)2]+ (m/z
655.18), [Cu(HL1a′)(CH3CN)]+ (m/z 402.10), [Cu(HL1a″)-
(CH3CN)]
+ (m/z 400.10). Moreover, attempts of the
chromatographic separation of the obtained compounds (on
SiO2 with MeOH as eluent) led to a new species [Cu(HL
1a′)-
(HL1d)]+ (m/z 537.15), in which one already oxidized ligand
HL1a′ in [Cu(HL1a″)2]+ lost the phenolic moiety. The
complex formation of HL1a″ in MeOH under heating at 50
°C resulted in two species [Cu(HL1a″)(HL1d)]+ (m/z 537.15)
and [Cu(HL1d)2]
+ (m/z 419.08), whereas under prolonged
heating (36 h) only [Cu(HL1d)2]
+ was detected, and the
formation of complex [Cu(HL1d)2Cl2] (5) was confirmed by
SC-XRD.
The potentially redox-active TSC ligands (HL1, (L2)−, and
HL3) in 1, 2′, and 3 proved to react slowly with oxygen in air.
Indeed, ESI mass spectra of methanolic solutions of 1, 2′, or 3
after a prolonged standing in air showed peaks with m/z
shifted by 2 amu to lower masses in agreement with an
oxidative dehydrogenation required for the formation of two-
electron oxidation products.
To finally determine the redox status of the 4-aminophenolic
moiety, the configurations adopted by the metal-free ligands in
the solid state and their protonation level in copper(II)
complexes SC-XRD studies were performed.
X-ray Crystallography of the Metal-Free Ligands
HL1−HL3 and Copper(II) Complexes 1′−3′. The results
of X-ray diffraction studies of TSCs HL1·C2H5OH, HL2 and
HL3 are presented in Figure 3, while those of [Cu(L1)Cl]·
CH3OH (1′·CH3OH), [Cu(L2)Cl] (2′), and [Cu(L3)Cl]·
CH3OH (3′·CH3OH) are in Figure 4. The HL1·C2H5OH
crystallized in the triclinic centrosymmetric space group P1̅,
while HL2 and HL3 crystallized in the monoclinic space groups
P21/c and P21/n, respectively. All three metal-free ligands
adopt an E configuration in terms of the nomenclature used for
the α-N-heterocyclic thiosemicarbazones41 with the imine
nitrogen in the s-trans position to the sulfur atom and the
pyridine N1 atom. All TSCs crystallized in the thione form
with the C7−S bond length of 1.6839(15), 1.683(4) and
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1.695(2) Å, respectively. The distribution of electron density
in the dimethylphenolic moiety is typical for aromatic systems.
The C11−O bond length of 1.3780(19), 1.370(4), and
1.380(2) Å, respectively, is also characteristic for phenols.
The molecules of the three proligands are not planar. The
strong deviation of the phenolic unit from the mean plane of
the thiosemicarbazone fragment can be estimated by a
comparison of the torsion angle ΘC7−N4−C8−C13 of 88.7(2)
and 78.4(4)° in the first two structures (Figure 3a,b) and
ΘC7−N5−C8−C13 and ΘC22−N10−C23−C28 of 52.5(3) and 54.2(3)°
in two crystallographically independent molecules of HL3
(Figure 3c).
In contrast to the structures of HL1 and HL2, the
asymmetric unit of HL3 consists of two molecules associated
in a centrosymmetric dimer via hydrogen-bonding interactions,
namely, N4−H···S2 [N4−H4 = 0.88 Å, H4···S2 = 2.48 Å,
N4···S2 = 3.3243(17) Å] and N9−H···S1 [N9−H9 = 0.88°,
H9···S1 = 2.47 Å, N9···S1 = 3.3341(17) Å]. A similar
centrosymmetric association was recently reported for
acetylpyrazine 4-N-phenyl thiosemicarbazone.54
The copper(II) complexes 1′·CH3OH and 3′·CH3OH
crystallized in the monoclinic centrosymmetric space group
P21/c, while 2′ crystallized in the triclinic centrosymmetric
space group P1̅ without any cocrystallized solvent. The
copper(II) adopts a square-planar coordination geometry in
all three structures (Figure 4). The thiosemicarbazones act as
tridentate monoanionic ligands binding to copper(II) via a
pyridine nitrogen atom, an azomethine nitrogen atom, and a
thiolate sulfur atom. The fourth coordination site in all
complexes is occupied by the chlorido coligand. Pertinent
bond distances and bond angles are quoted in the legend to
Figure 3. ORTEP views of HL1−HL3 with thermal ellipsoids at the
50% probability level. Selected bond distances (Å) and torsion angles
(deg): (a) HL1: C6−N2 1.280(2), N2−N3 1.3701(18), N3−C7
1.357(2), C7−S 1.6839(15), C7−N4 1.331(2), N4−C8 1.442(2),
C11−O1 1.3780(19); ΘC7−N4−C8−C13 − 88.7(2); (b) HL2: C6−N2
1.287(4), N2−N3 1.374(4), N3−C7 1.363(4), C7−S 1.683(4), C7−
N4 1.326(4), N4−C8 1.446(4), C11−O 1.370(4); ΘC7−N4−C8−C13 −
78.4(4); (c) HL3: C4−N2 1.361(3), C6−N3 1.288(2), N3−N4
1.385(2), N4−C7 1.343(2), C7−S1 1.695(2), C7−N5 1.342(3),
N5−C8 1.430(2), C11−O1 1.380(2); ΘC7−N5−C8−C13 52.5(3).
Figure 4. ORTEP views of 1′−3′ with thermal ellipsoids at the 50%
probability level. Selected bond distances (Å), bond angles (deg) and
torsion angles (deg) in 1′: Cu−N1 2.005(2), Cu−N2 1.962(2), Cu−
S 2.2325(7), Cu−Cl 2.2507(7), C11−O1 1.370(4); N1−Cu−N2
81.77(9), N2−Cu−S 84.07(7), ΘC7−N4−C8−C13 −0.8(5); in 2′: Cu−
N1 2.022(4), Cu−N2 1.952(4), Cu−S 2.2636(16), Cu−Cl
2.2215(15), C11−O1 1.370(6); N1−Cu−N2 80.76(17), N2−Cu−S
84.46(12), ΘC7−N4−C8−C13 −2.1(8); in 3′: Cu−N1 2.025(2), Cu−N3
1.961(2), Cu−S 2.2432(8), Cu−Cl 2.2636(8), C11−O1 1.374(4);
N1−Cu−N3 81.58(10), N3−Cu−S 83.40(7), ΘC7−N5−C8−C13 9.4(5).
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Figure 4. The same coordination geometry of a copper(II)
bound by a monoanionic thiosemicarbazone and a mono-
dentate coligand was reported for [CuCl(mPip-FTSC−H)]·
0.15CH3OH,
55 [Cu(L1)(μ-Cl)]Cl, and [Cu(L2)(μ-Cl)]Cl·
H2O, where ligands L1 and L2 represent 3-methyl-5-oxo-1-
phenyl-3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-
pyrazolin-4-carboxaldehyde TSC, respectively.56
A comparison of the Cu(II) to TSC ligand bond lengths in
1′ with those in the copper(II) complex with pyridine-2-
carboxaldehyde thiosemicarbazone57 (Cu−N1 = 2.034(4),
Cu−N2 = 1.975(3), Cu−S = 2.278(1) Å) shows that these are
statistically significantly shorter in 1′. This difference is
probably due to the formation of centrosymmetric associates
via intermolecular interactions with the shortest contact Cu···Si
= 2.760(2) Å and not due to the presence of a phenolic moiety
at N4. The interatomic repulsions in the copper(II) complex
with a 4 + 1 coordination geometry are expected to be stronger
than those in 1′, in which the Cu(II) is four-coordinate. In
another complex [CuLCl]2[Cu(pic)2] (with HL = pyridine-2-
carboxaldehyde thiosemicarbazone and pic− = pyridine-2-
carboxylate), in which the intermolecular contacts are over 3 Å,
the Cu(II) to TSC bond distances are shorter and very similar
to those in 1′ (Cu−N1 = 2.005(8), Cu−N2 = 1.942(9), Cu−S
= 2.264(3) Å).48 The metric parameters in the copper(II)-
ligand chromophore of [Cu(triapine-H)Cl](H3O)Cl (Cu−Npy
= 2.031(8), Cu−Nhydrazine = 1.937(9), Cu−S = 2.281(3) and
Cu−Cl = 2.2493(5) Å) are statistically the same as those in 3′,
except Cu−S, which is by ca. 0.04 Å (>12σ) shorter in 3′ than
in the copper(II) complex with triapine. This is likely due to
different protonation states of the ligands in the two
complexes, even though the authors described the triapine
ligand in its copper(II) complex as a monoanion with an extra
proton at a cocrystallized water molecule.58
Note that the organic ligands in all three complexes are
almost planar in contrast to the situation described previously
for the metal-free ligands. The value of the torsion angle
ΘC7−N4−C8−C13 for 1′·CH3OH and 2′ (Figure 4a,b) increased
from −88.7(2) and −78.4(4)° in HL1 and HL2 to −0.8(5) and
−2.1(8)°, respectively. Analogously, the torsion angle
ΘC7−N5−C8−C13 of 52.5(3) in HL3 becomes of 9.4(5)° in 3′·
CH3OH upon coordination to copper(II).
As for the metal-free TSCs, the phenolic moiety remained
intact in all three complexes, namely, in its original oxidation
state. The distribution of electron density over the aromatic
phenolic ring is well-comparable to that in the TSCs.
X-ray Crystallography of Oxidized Products. The
results of X-ray diffraction studies of oxidized organic species
HL1a′, HL1a″, HL2b, HL2e, and HL2c″·0.5CHCl3 are displayed
in Figure 5 and Figure S6, while those of copper(II) complexes
with oxidized ligands 4−6 are shown in Figure 6 and Figure
S7. The oxidized species HL1a′ and HL1a″ crystallize in the
monoclinic space groups P21/n and Cc, respectively. The
molecule HL1a′ is almost planar, while in HL1a″ the moiety at
N4 slightly deviates from planarity. The dihedral angle
ΘC7−N4−C8−C13 is of 5.8(3)°. Both contain a thiadiazole five-
membered ring. The distribution of electron density in them is
very similar. In contrast, the bond length distribution in the
aryloxide moiety is quite different. In the two-electron oxidized
product HL1a′ the distribution of electron density is in
agreement with that of the 3,5-dimethyl-1,4-aminophenolic
moiety, while in the four-electron oxidized species HL1a″ the
electron density agrees with that of the 3,5-dimethyl-1,4-
benzoquinone imine unit (see legend to Figure 5a,b). In
particular, the C11−O1 bond length in these two compounds
is quite different at 1.3820(16) and 1.226(3) Å, respectively.
The X-ray diffraction structure of HL2b confirmed the two-
electron oxidation of the original ligand HL2 and the formation
Figure 5. ORTEP views of two-electron and four-electron oxidized
species of (a) HL1a′ and (b) HL1a″, as well as of products that
resulted from an oxidation of HL2, namely, of (c) HL2b and (d)
HL2c″·0.5CHCl3. Selected bond distances (Å) and torsion angles
(deg) in (a) HL1a′: C6−N2 1.3029(17), N2−N3 1.3739(15), C6−S
1.7405(14), C7−S 1.7382(13), C8−C9 1.3878(19), C9−C10
1.4003(18), C10−C11 1.3927(19), C11−C12 1.4006(19), C12−
C13 1.3922(19), C11−O1 1.3820(16); ΘC7−N4−C8−C9 1.0(2); in (b)
HL1a″: C6−N2 1.305(3), N2−N3 1.382(2), C6−S 1.727(2), C7−S
1.734(2), C8−C9 1.458(3), C9−C10 1.341(3), C10−C11 1.480(3),
C11−C12 1.491(3), C12−C13 1.342(3), C11−O1 1.226(3);
ΘC7−N4−C8−C13 5.8(3); in (c) HL2b: C6−N2 1.485(2), N2−N3
1.247(2), N3−C7 1.472(2), C7−S 1.6465(18), C7−N4 1.325(2),
N4−C6 1.479(2), C11−O 1.3728(18), N4−C8 1.4409(19); in (d)
HL2c″·0.5CHCl3: C6−N2 1.306(4), N2−N3 1.394(4), N3−C7
1.296(4), C7−N4 1.388(4), N4−C8 1.311(4), C8−C9 1.444(4),
C9−C10 1.340(4), C10−C11 1.488(5), C11−O1 1.234(4), C11−
C12 1.496(4), C12−C13 1.349(4), C13−C8 1.461(4), C13−S1
1.745(3).
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of the TAT ring, while that of HL2c″ confirmed the further
two-electron oxidation of HL2c′. The bond-length distribution
in the molecule of HL2c″ indicates the presence of the
benzo[d]thiazol-6-one moiety. The double-bond character of
N3−C7 1.296(4) indicates the formation of this four-electron
oxidation product from the two-electron oxidation product
HL2c′ by the loss of two electrons and two protons.
The X-ray diffraction study of 4 (Figure 6a) revealed that
the ligand underwent an oxidative dehydrogenation accom-
panied by the intramolecular cyclization via a C−S coupling
reaction between a phenolic carbon and a thione group into a
five-membered thiazole ring instead of the expected oxidative
dehydrogenation (two-electron oxidation accompanied by the
loss of two protons) of the 3,5-dimethyl-1,4-aminophenol unit
with formation of a 3,5-dimethyl-1,4-benzoquinone imine
moiety (see Chart 2, Scheme 1). This intramolecular sulfur
arylation resulted in the change of coordination mode, so that
the thioether sulfur atom with diminished electron-donor
properties is not involved in the coordination to copper(II).
This is in agreement with the coordination chemistry of
isothiosemicarbazones,59 which as a rule do not use a sulfur
atom for coordination to first-row transition metals. In this
context, it is worth mentioning that the binding of
isothiosemicarbazones to zinc(II) and copper(II) via a
thioether sulfur atom has been documented quite recently,60
when bulkier than chlorido coligands, for example, iodido and
bromido, were involved in coordination to the metal. Complex
4 might be one of the products of the oxidation of copper(II)
complexes over time in methanol by air oxygen. Some rare
examples of a thiosemicarbazone cyclization with the thiazole
ring formation due to the coordination to copper(II) were
recently reported (iminodiacetate−thiosemicarbazones and N-
phenylthiosemicarbazones).52,53,61 The new ligand obtained by
the intramolecular cyclization in Cu(HL1)Cl2 belongs to the
class of biologically active substituted 2-hydrazinylbenzothia-
zoles, which showed anticancer activity themselves as well as
upon coordination to different metals.62−65 Two molecules of
complex 4 are associated into a centrosymmetric dimer via two
intermolecular μ-chlorido bridges as shown in Figure S7.
The molecular structure of 5 shown in Figure 6b indicates a
strongly tetragonally distorted six-coordinate geometry of
copper(II), in which two pyridine-thiadiazole ligands act as
bidentate and occupy the equatorial sites in a trans mutual
arrangement and two quite weakly bound chlorido coligands in
axial positions. Taking into account the interatomic Cu−Cl
separation (2.8116(3) Å) the complex can also be described as
square-planar.
As in 4, the coordinated ligand in 6 acts as tridentate and
binds to copper(II) via atoms N1, N2, and N4. However, while
4 is square-planar, 6 is very close to square-pyramidal (τ5 =
0.16).66 The organic ligand is monoanionic in 4, while neutral
in 6. An additional coordination of chlorido coligands
counterbalances the 2+ charge of the central atom.
Figure 6. ORTEP views of [Cu(L1c′)Cl] (4), [Cu(HL1d)2Cl2] (5),
and [Cu(HL2c′)Cl2] (6) with thermal ellipsoids at the 50%
probability level. Selected bond distances (Å) and bond angles
(deg) in (a) 4: Cu−N1 2.054(4), Cu−N2 1.956(4), Cu−N4
2.001(3), Cu−Cl 2.2575(12), C11−O 1.370(5); N2−Cu−N1
80.02(15), N2−Cu−N4 78.59(14); in (b) 5: Cu−N1 2.0384(11),
Cu−N2 2.0089(11), Cu−Cl 2.8116(3), N2−Cu−N1 99.32(4); in (c)
6: Cu−N1 2.0329(16), Cu−N2 1.9854(16), Cu−N4 2.0358(16),
Cu−Cl1 2.2100(5), C11−O 1.374(2); N2−Cu−N1 78.00(16), N2−
Cu−N4 79.31(6).
Figure 7. UV−vis absorption spectra recorded for proligand HL1 in the pH ranges of (a) 1.00−4.95 and (b) 5.49−11.82. cHL = 50 μM; 30% (v/v)
DMSO/H2O; I = 0.1 M (KCl); T = 25 °C.
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To understand the difference in protonation states and
reactivity of the originally prepared complexes and those
isolated upon crystallization from diluted methanolic solutions
equilibrium studies were performed on the ligands and their
copper(II) complexes.
■ SOLUTION EQUILIBRIUM STUDIES
Proton Dissociation Processes and Lipophilicity of
the Ligands. Proton dissociation constants (pKa) of drug
molecules indicate the actual protonation state and the charge
at a given pH, and therefore pKa are important parameters that
affect the pharmacokinetic properties as well. The N-terminally
monosubstituted TSCs HL1−HL3 belong to the family of α-N-
pyridyl TSCs; thus, they possess the pyridinium (PyH)+ and
the hydrazinic-NNH as proton dissociable groups besides the
phenolic moiety. Since these TSCs and their copper(II)
complexes have a limited water solubility, the equilibrium
studies were performed by UV−vis spectrophotometry in a
30% (v/v) DMSO/H2O solvent mixture using relatively low
concentrations (50 μM). Representative UV−vis spectra
recorded for HL1 at various pH values are shown in Figure 7a.
On the basis of the spectral changes two well-separated
deprotonation processes were observed between pH 2 and 11.
The first proton dissociation step taking place at pH < 5 is
accompanied by a blue shift, and the λmax is shifted from 362 to
322 nm. This deprotonation step is attributed to the proton on
the pyridinium nitrogen (PyH+). Upon an increase of the pH a
new process occurred as evidenced by a new band in the range
of 350−450 nm (Figure 7b) and an isosbestic point at 350 nm,
namely, the deprotonation of the hydrazinic nitrogen. In the
strongly basic pH range (pH > 11.2) new broad bands appear
at 400−600 nm (Figure 7b) with irreversible spectral changes
most likely due to an oxidation of the TSC by the air oxygen.
Therefore, only two pKa values could be determined (Table
1) based on the deconvolution of the UV−vis spectra recorded
at pH < 11.2 for HL1 (molar absorbance spectra are seen in
Figure S8a) as the oxidation hindered the accurate
determination of the pKa for the aromatic OH group. Two
pKa values were computed for HL
2 from the UV−vis titration
data (Figure S9) as well; however, only one pKa was obtained
in the case of HL3 (Table 1), namely, that for the
deprotonation of the PyH+, since the proton dissociation of
the hydrazinic nitrogen and the oxidation of the TSC were
partly overlapped. On the basis of the determined pKa values, it
can be concluded that the presence of the electron-donating
methyl group in HL2 results in a significant increase of both
pKa values when compared to that of HL
1. A similar behavior
was reported for the analogous 2-formylpyridine and 2-
acetylpyridine TSC in our previous work.67 The pKa of the
PyH+ group was also increased significantly by the addition of
the electron-donating amine group at the pyridine ring, in
agreement with data reported previously for the FTSC and
triapine.68 All proligands are air-sensitive in the strongly basic
pH range (pH > 11). Concentration distribution curves were
computed for them at pH < 11 (see Figure S8b for HL1)
revealing that their neutral forms predominate at a
physiological pH.
The solution stability of the proligands was monitored at pH
7.4 by spectrophotometry. The UV−vis spectra recorded over
4 h revealed no measurable spectral changes, suggesting that
the oxidation of these proligands does not take place (or just
very slowly) in an aqueous solution at a physiological pH.
However, HL2 showed a certain level of slow decomposition at
pH 1.5, namely, a 6% absorbance decrease at 354 nm in ∼3 h
(Figure S10), which is most likely the consequence of the less
extended conjugation in the molecule due to the cleavage of
the CN Schiff base bond, as it was also reported for 2-
acetylpyridine TSC.67 Thus, the rate of this acid-catalyzed
reaction is increased with the increasing number of methyl
groups present in the α-N-pyridyl TSC.
Besides pKa values, lipophilicity is also an important
pharmacological property of a drug, as it strongly influences
the ability of the compound to pass through biological
membranes. Therefore, distribution coefficients (log D7.4) were
determined using the shake-flask method in an n-octanol-
buffered aqueous solution at pH 7.4 (Table 1). The log D7.4
values indicate the moderate lipophilic character of the
proligands. The substitution at the end nitrogen atom of the
thosemicarbazide moiety and the presence of a methyl group at
the Schiff base bond induce a somewhat higher lipophilicity.
The presence of the phenolic moiety undoubtedly increases
the log D7.4 values compared to those of FTSC (+0.73),
67
AcTSC (+1.02)67 and triapine (+0.85).69
In summary, these TSCs are stable in their neutral form in a
quite broad pH range (including pH 7.4).
Solution Stability and Redox Properties of the
Copper(II) Complexes. The metal complexes often undergo
transformation processes upon dissolution, such as proto-
nation, deprotonation, or dissociation to a metal-free ligand
and metal ion depending on the pH, their concentration, and
the solution speciation. The knowledge of the actual chemical
form of the biologically active metal complexes in solution
close to physiologically relevant conditions is quite important
to elucidate the mechanism of action. Therefore, the solution
Table 1. pKa Values Determined by UV−vis Titrations in 30% (v/v) DMSO/H2O and log D7.4 (n-Octanol/Water) Values of
the TSCs HL1−HL3 and Their Complexesa
method HL1 HL2 HL3
pKa (PyH
+) UV−vis 3.01 ± 0.01 3.59 ± 0.02 3.95 ± 0.04
pKa (NNH) UV−vis 10.55 ± 0.01 11.08 ± 0.02 nd
log D7.4 (proligand) partitioning +1.30 ± 0.03 +2.1 ± 0.1 +1.67 ± 0.01
log K′5.9 (complex) EDTA displacement 9.67 ± 0.01 ndb 9.78 ± 0.01
log D7.4 (complex) partitioning −0.40 ± 0.06 ndb −0.42 ± 0.03
kobs (min
−1) (complex) in 30% DMSO UV−vis (with GSH) 0.033 ± 0.004 ndb 0.035 ± 0.004
kobs (min
−1) (complex) in 60% DMSO UV−vis (with GSH) 0.021 ± 0.001 too slowc 0.024 ± 0.004
aConditional stability constants (log K′5.9) of the complexes determined by UV−vis EDTA displacement studies in 30% (v/v) DMSO/H2O and
rate constants (kobs) obtained for the redox reaction of the complexes with GSH (pH = 7.4 (50 mM HEPES); ccomplex = 25 μM; cGSH = 1.25 mM in
30% (v/v) DMSO/H2O); ccomplex = 12.5 μM; cGSH = 600 μM in 60% (v/v) DMSO/H2O) {T = 25 °C; I = 0.1 M (KCl)}.
bNot determined (nd)
due to the bad solubility of the complex under the conditions. cRate constant could not be determined due to the very slow redox reaction.
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stability of the copper(II) complexes (Cu(HL1)Cl2, [Cu(L
2)-
Cl], and Cu(HL3)Cl2) was studied by UV−vis spectropho-
tometry. The simple α-N-pyridyl TSCs (e.g., triapine, FTSC)
generally form very stable monoligand copper(II) complexes,
and the species in which the monoanionic ligand is
coordinated via the (Npyridine,N,S
−) mode predominates in a
wide pH range at a 1:1 metal-to-ligand ratio.68 At lower pH
this type of complex is protonated, and thus the neutral ligand
is bound via (Npyridine,N,S) donor atoms, while a mixed
hydroxido complex with the (Npyridine,N,S
−)(OH) coordina-
tion pattern is formed in the basic pH range. On the basis of
the close structural similarities between HL1−HL3 and the
listed TSCs with a simpler scaffold, the formation of the same
type of complexes is feasible. UV−vis titrations were
performed with the complexes in a 30% (v/v) DMSO/H2O
solvent mixture, and representative spectra are shown for
Cu(HL1)Cl2 in Figure 8. The spectra remain intact in a broad
pH range (2.7−7.6), and an absorption band is observed with
λmax at 406 nm being typical for a S→ Cu charge transfer. This
finding indicates the dominant presence of only one kind of
complex, which is most probably the species with the
(Npyridine,N,S
−) tridentate coordination mode. By decreasing
the pH the λmax is hypsochromically shifted to 322 nm. The
presence of the isosbestic point at 362 nm implies that only
two species are involved in this equilibrium. As the spectrum
recorded at pH 1.01 significantly differs from that of the TSC,
this equilibrium corresponds to the protonation of the complex
at the noncoordinating hydrazinic nitrogen (Chart S1) rather
than to its dissociation to the free metal ion and ligand. This
process is not completed when the pH decreases to 1, and a
pKa value less than 1.5 could be estimated. When the pH is
increased, two overlapping processes are suggested to take
place at pH > 8 via the continuous bathochromic shift of the
absorption maximum, and pKa values of 9.80 ± 0.01 and 11.02
± 0.01 were computed. In this pH range most probably the
coordinated water molecule deprotonates, and a mixed
hydroxido complex is formed along with the deprotonation
of the phenolic group of the bound ligand. Similar spectral
changes were monitored for Cu(HL3)Cl2, and pKa < 1.5 was
estimated for the process in the acidic pH range as well.
However, the formation of precipitate (significant baseline
elevation and absorbance decrease in the whole wavelength
range) at pH > 8 hindered the calculation of the proton
dissociation constants of the complexes from spectra collected
in this pH range. Unfortunately, during the titration of
[Cu(L2)Cl] the formation of a precipitate was observed
already at the acidic pH; thus, the deprotonation processes
could not be evaluated.
The copper(II)−TSC complexes are often redox-active
under physiological conditions, which has an impact on their
cytotoxicity. To investigate whether complexes [Cu(L1)]+,
[Cu(L2)]+, and [Cu(L3)]+ can be reduced by the most
abundant low molecular mass cellular reductant, GSH,
spectrophotometric measurements were performed on their
direct reaction under strictly anaerobic conditions at pH 7.4.
First, the assay was performed in the presence of 30% DMSO
using a 25 μM complex concentration. However, the limited
solubility of [Cu(L2)]+ did not allow the measurement.
Therefore, the assay was also performed in the presence of
60% DMSO at a lower (12.5 μM) concentration for all the
three complexes. The spectral changes are shown in Figure 9
for [Cu(L1)]+ and [Cu(L3)]+ complexes in the presence of a
large excess of GSH in 30% (v/v) DMSO/H2O. After the
complexes were mixed with GSH, a well-detectable change is
observed due to the formation of ternary complexes via the
coordination of GSH as it was reported for several TSC
complexes.70,71 Then the spectral changes show the
absorbance decrease at the λmax of the S → Cu charge transfer
band of the complexes. The final spectra show a strong
similarity to those of HL1 and HL3 at λ > 310 nm suggesting
the release of the TSCs. However, in this case the reduction is
responsible for the liberation of the TSCs and copper(I),
which forms complexes with GSH (that is in high excess in the
sample). Copper(I) favors a tetrahedral coordination environ-
ment, while HL1 and HL3 as planar tridentate ligands cannot
satisfy these requirements and accommodate the cation. This
contradiction is a driving force for a complex destabilization,
especially in the presence of GSH, which can efficiently bind
copper(I).64 In addition, a one-electron reduction increases the
Figure 8. UV−vis absorption spectra recorded for complex Cu-
(HL1)Cl2 in the pH range of 1.01−12.20 (solid lines) and for HL1 at
pH 1.01 (dashed gray line). ccomplex/HL = 50 μM; 30% (v/v) DMSO/
H2O; I = 0.1 M (KCl); T = 25 °C.
Figure 9. Time-dependent changes of the UV−vis spectra of (a) Cu(HL1)Cl2 and (b) Cu(HL3)Cl2 in the presence of 50 equiv of GSH at pH 7.4
under anaerobic conditions. ccomplex = 25 μM; cGSH = 1.25 mM; pH = 7.40; 30% (v/v) DMSO/H2O; I = 0.1 M (KCl); T = 25 °C.
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basicity of the coordinated TSCs facilitating their protonation
and dissociation from the copper(I).72 Note, however, that the
process was reversible, as bubbling oxygen into the samples
regenerated the starting spectra. Complex [Cu(L2)]+ behaved
differently, as only minor spectral changes were seen upon
treatment with GSH in 60% (v/v) DMSO/H2O (Figure
S11b). From the measured absorbance−time curves rate
constants (kobs) were calculated (Table 1). Similar reduction
rates for [Cu(L1)]+ and [Cu(L3)]+ complexes were obtained,
and somewhat lower kobs values were found in the presence of
the higher fraction of DMSO. Notably, ascorbate, which is a
weaker reducing agent compared to GSH and is found in
higher concentration in the extracellular fluids, was not able to
reduce these complexes under the same conditions. On the
contrary, the more powerful reducing agent DTT could reduce
[Cu(L1)]+, [Cu(L2)]+, and [Cu(L3)]+ in a very fast reaction.
The reduction was complete within several seconds (at 12.5
μM complex and 600 μM DTT concentrations in the presence
of 60% DMSO, Figure S11c,d). In this case, the reaction was
reversible upon exposure to O2 only for [Cu(L
2)]+.
Overall, the solution equilibrium data provide further
evidence that the complex [Cu(L)]+ with the coordinated
monoanionic ligand predominates in a wide pH range. In order
to obtain a deeper insight into the observed behavior of both
metal-free ligands and their copper(II) complexes in the
presence of oxidants (atmospheric oxygen) and reductants
(GSH and ascorbate) spectroelectrochemical investigations
were also performed.
Electrochemistry and Spectroelectrochemistry. Cyclic
voltammograms of 1, 2′, and 3 in DMSO/n-Bu4NPF6 recorded
with a glassy carbon (GC) working electrode at a scan rate of
100 mV s−1 showed a redox activity in both cathodic and
anodic regions. Copper(II) undergoes an electrochemically
irreversible or quasi-reversible reduction to copper(I) at Epc =
−0.83 V for 1 and −0.93 V versus Fc+/Fc for both 2′ and 3
(Figure 10a). Notably, the corresponding ligands are not
redox-active in the cathodic region (data not shown). An
irreversible oxidation was observed for these complexes, which
was identified as a two-electron oxidation of the TSCs with a
release of two protons. A two-electron oxidation was confirmed
by a comparison of the reduction peak (one-electron Cu(II)→
Cu(I) redox process) and the oxidation peak of 2′ taken in
equivalent amounts as shown in Figure 10b. In addition, an
electrolysis of HL1 at 1000 mV versus Ag/AgCl in CH3CN in
the presence of 0.2 M n-Bu4NPF6 generated a mixture of
several products from which HL1a′ and HL1a″ were separated
on silica. ESI-MS and 1H NMR spectra were identical with
those of the products obtained by an oxidation of HL1 with
DDQ as mentioned previously.
The oxidation peak of the TSC ligand was observed at Epa =
+0.06 V for 1 and 2′ and at +0.04 V for 3, and it is negatively
shifted in comparison to the corresponding metal-free ligands
(Epa = +0.21 V for HL
1, +0.24 V for HL2, and +0.18 V for HL3
(all vs Fc+/Fc at a scan rate of 100 mV s−1)), as shown for 1
and its corresponding metal-free ligand HL1 in Figure 11a,b,
respectively. There are also significant changes in the shape
and intensity of cyclic voltammograms upon the second
oxidation scan (see red traces in Figure 11a,b), which indicate
a further oxidation of the products obtained after the first
oxidation in DMSO, in line with the chemical oxidation of the
compounds. Note that, in a proton-donating solvent, the
potentials of both reduction and oxidation processes were
shifted to the more positive values versus the internal potential
standard Fc+/Fc, and additionally, a broad reduction peak
Figure 10. (a) Cyclic voltammograms of 0.5 mM 1 (black trace), 2′ (red trace), and 3 (green trace) in DMSO/n-Bu4NPF6 at a GC working
electrode at the scan rate of 100 mV s−1; (b) comparison of the reduction and the oxidation peak of 2′ (scan rate of 100 mV s−1).
Figure 11. Cyclic voltammograms of 0.5 mM of (a) 1 and (b) the corresponding ligand in DMSO/n-Bu4NPF6 and of (c) 1 in MeOH/LiClO4 at
the GC working electrode, at scan rate of 100 mV s−1.
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appeared during the reverse scan in the cyclic voltammogram
at a strongly negatively shifted potential (Figure 11c). A
distinct oxidation pattern of the corresponding voltammo-
grams in protic media is caused by the involvement of protons
in the process in accordance with chemical oxidations
discussed previously and the well-known reaction mechanism
proposed for the quinone-like systems.70,71
Similar redox behavior was observed for the anodic
oxidation of HL1a′ in DMSO with several new redox-active
species, which appeared upon the first and the second
voltametric scans (Figure S12a). However, the oxidized 1,4-
benzoquinone imine species HL1a″can be reversibly reduced in
the cathodic part (Figure S12b) with a voltammetric pattern
characteristic for the electrochemistry of quinones in aprotic
media.72 Moreover, EPR spectroelectrochemistry confirmed
the formation of an anion radical at the first reduction peak
(see inset in Figure S12b). A rich hyperfine splitting and a g-
value of 2.0046 points to the spin delocalization and
contribution of heteroatom (presumably nitrogen) to the g-
value.
To support the assignment of the redox processes described
previously, EPR/UV−vis spectroelectrochemical measure-
ments were performed, and the results are shown for 1 in
Figures 12 and 13. The UV−vis spectrum of 1 exhibits two
absorption bands at 276 and 428 nm, where the first one is due
to the absorption of the TSC ligand, while the second one can
be attributed to the ligand-to-metal (S → Cu) charge transfer
(LMCT).73,74 Upon the cathodic reduction of 1 in the region
of the first reduction peak a new broad absorption band at 331
nm appears with a simultaneous decrease of the initial optical
bands at 276 and 428 nm via an isosbestic point at 302 nm
(Figure 12). An analogous spectroelectrochemical response
was observed for 2′ as shown in Figure S13. This observation
is different from that encountered by the reduction of the
copper(II)−TSC complexes by GSH (vide supra), which led
to the liberation of the ligand and formation of the copper(I)
complex with GSH. In the spectroelectrochemical experiment
in the absence of strong Cu(I) complexing agents, such as
GSH, the TSC ligand may coordinate to Cu(I) and form a
linear or tetrahedral complex. Upon the voltammetric reverse
scan, a nearly full recovery of the initial optical bands was
observed, which confirms the relatively good stability of
cathodically generated Cu(I) complex with HL2 and, thus, the
chemical reversibility of this redox process. Rare examples of
four- and three-coordinate copper(I) complexes with poten-
tially tridentate and bidentate thiosemicarbazones were
reported previously.75,76 The room-temperature X-band EPR
spectrum of 1 showed a typical signal for d9 Cu(II) species,
which decreased stepwise upon a cathodic reduction at the first
cathodic peak. This is in line with the metal-centered reduction
and formation of EPR-silent d10 Cu(I) species10 (see inset in
Figure 12b). EPR spectra of 1, 2′, and 3 measured in frozen n-
Bu4NPF6/DMSO at 77 K show a characteristic axial symmetry
(g∥ > g⊥ > ge) implying a square-planar coordination and the
presence of one dominating species in DMSO (Figure S14).
The in situ cyclic voltammogram and simultaneously
recorded evolution of UV−vis spectra upon an anodic
oxidation of 1 in DMSO provide further evidence for the
ligand-based irreversible oxidation. Spectral changes accom-
panying the oxidation of 1 are shown in Figure 13. These
changes are characteristic for the other two complexes 2′ and 3
as well. Note that, in the region of the first oxidation peak, new
optical bands at 295 and 356 nm appear with a simultaneous
decrease of the initial absorption with a maximum at 428 nm
(Figure 13a). However, the product formed upon oxidation is
not reduced back during the reverse voltammetric scan (Figure
13b), indicating the chemical irreversibility of the redox
process. In the EPR spectroelectrochemistry of 1 in DMSO/n-
Bu4NPF6, no changes of the EPR signal were detected upon
the oxidation at the first anodic peak, providing evidence of the
two-electron oxidation process taking place on the TSC ligand.
The remarkable stability of copper(II) complexes 1, 2′, and
3 at a physiological pH, their moderate lipophilic character
(log D7.4 = −0.4 to −0.42) and copper(II)/copper(I) redox
activity (Ered = −0.83 to −0.93 V vs Fc+/Fc) in a biologically
relevant window of redox potentials (−0.4 to +0.8 V vs NHE
or −1.04 to 0.16 V vs Fc/Fc+) prompted the investigation of
their antiproliferative activity in cancer cell lines.
■ INHIBITION OF CELL VIABILITY AND APOPTOSIS
ASSAY
Cytotoxicity of the TSCs, Their Oxidized Products
and Copper(II) Complexes. The in vitro cytotoxicity of the
TSCs HL1−HL3, copper(II) complexes Cu(HL1)Cl2, [Cu-
(L2)Cl], and Cu(HL3)Cl2, and oxidized TSCs HL
1a′, HL1a″,
and HL2c′·CH3COOH was tested in the doxorubicin-sensitive
Colo205 and the multidrug-resistant Colo320 human colonic
adenocarcinoma cell lines as well as in normal human
embryonal lung fibroblast cells (MRC-5) by the colorimetric
MTT assay. The data that resulted (expressed as the half-
maximal inhibitory concentration (IC50)) are collected in
Figure 12. Spectroelectrochemistry of 1 in n-Bu4NPF6/DMSO in the
region of the first cathodic peak: (a) potential dependence of UV−vis
spectra with the corresponding in situ cyclic voltammogram (Pt-
microstructured honeycomb working electrode, scan rate of 5 mV
s−1); (b) evolution of UV−vis spectra in 2D projection upon forward
scan. (inset) Evolution of EPR spectra measured at the first reduction
peak using a Pt mesh working electrode.
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Table 2 and compared with those for triapine, doxorubicin,
and CuCl2.
The metal-free ligands were either devoid of cytotoxicity or
showed a weak response; only HL1 and HL3 revealed a
somewhat higher activity against Colo320 and Colo205 cells,
respectively, even though it was inferior to that of triapine.
Notably, the copper(II) complexes are quite cytotoxic. So the
effect of the copper(II) coordination is obvious in all cases.
Low IC50 values (0.16−2.2 μM) were obtained for Cu(HL1)-
Cl2 and [Cu(L
2)Cl] in both cancer cell lines (Colo205 and
Colo320). To gain further insights into the cytotoxic behavior
of the compounds, apoptosis induction by lead compounds
HL1 and [Cu(L2)Cl] was investigated by a flow cytometry
analysis of multidrug-resistant Colo320 cells stained with
Annexin-V-FITC and propidium iodide (PI). The two
compounds that displayed the highest cytotoxicity against
this cell line were tested at two concentrations in the range of
their IC50 values. 12H-Benzophenothiazine (M627) and
cisplatin were used as positive controls. The fluorescence of
PI (FL3) was plotted versus Annexin-V fluorescence (FL1) as
shown in Figure 14 for the positive controls and for the tested
compounds at a chosen concentration. The percentage of the
gated events regarding the early apoptosis, the late apoptosis
and necrosis, and cell death is quoted in Table S8. According
to these data, both compounds studied, HL1 and [Cu(L2)Cl],
can be considered as efficient apoptosis inducers.
The antiproliferative activity of 1 and 2′ in the normal cells
(MRC-5) was only slightly lower than in Colo205 and
Colo320 cells, indicating a quite moderate selectivity for cancer
cells. Complex Cu(HL3)Cl2 was found to be less cytotoxic
compared to the other two complexes tested, and the IC50
values are similar to those of the copper(II) chloride, while the
selectivity for cancer cells is obvious in this case (SI > 3). It is
worth mentioning that the analogous α-N-pyridyl thiosemi-
carbazones, that is, FTSC, AcTSC, and triapine, were reported
to be cytotoxic in the low micromolar concentration range
against several human cancer cells, the latter being the most
potent among them (IC50 values reported for triapine: 0.4−2.6
μM (in good agreements with the data quoted in Table 5), for
FTSC: 1.9−10.6 μM, for AcFTSC: 2.5−3.6 μM in SW480,36
MES-SA,36 MES-SA/Dx5,36 HL60,58 41M,80 SK-BR-380).
Their Cu(II) complexes were reported to possess a similar
or even weaker cytotoxicity compared to the metal-free ligands,
in contrast to complexes studied in the present work, which
might indicate a distinct mode of action. It is also of note that
the two-electron oxidized product HL2c′ revealed a superior
antitumor activity in the two cancer cell lines over that of
HL1a′ and HL1a″. In agreement with this, closely related 2-
formyl- and 2-acetylpyridine 2-benzothiazolyl hydrazones were
shown to be potent cytotoxic drugs against a series of 17
murine (e.g., L1210 lymphoid leukemia, P388 lymphocytic
leukemia) and human cancer cells (e.g., HeLa cervix
carcinoma, bone SOS, lung MB9812, lung A549). In addition,
these compounds showed selectivity for the multidrug-resistant
doxorubicin-selected uterine sarcoma cell line MES-SA/Dx5
over parental or sensitive MES-SA cells.78,79
Tyrosyl Radical Reduction in mR2 RNR. The TSCs
HL1−HL3 and their copper(II) complexes 1, 2′, and 3 were
found to effectively quench the tyrosyl radical in mR2 RNR in
the presence of an external reductant (DTT). The time-
dependent tyrosyl radical reduction in mR2 RNR by equimolar
concentrations of TSCs and their respective copper(II)
complexes, under reducing conditions, is shown in Figure 15.
The mR2 inhibition potency follows the order HL1 ≈ triapine
> HL3 > HL2. The coordination to copper(II) was found to
increase the tyrosyl radical quenching potential for all TSCs,
which is in agreement with the observed lowering of IC50
values in all cancer cell lines (Table 2). Complex 1 was shown
to be as efficient as triapine,17 reducing 100% of the tyrosyl
radical in 3 min. Complexes 2′ and 3 exhibited comparable
reduction kinetics despite the fact that, among the investigated
TSCs, HL2 was found to be most inefficient. The favorable
Figure 13. UV−vis spectra measured simultaneously (a) upon anodic oxidation of 1 in the region of the first anodic peak (inset: time evolution of
EPR spectra acquired at the first anodic peak) and (b) upon the back scan (inset: the corresponding in situ cyclic voltammogram).
Table 2. In Vitro Cytotoxicity (IC50 Values in μM) of Metal-
Free Ligands HL1−HL3, Copper(II) Complexes
Cu(HL1)Cl2, [Cu(L
2)Cl], and Cu(HL3)Cl2, and, of the
Oxidized Species HL1a′, HL1a″, and HL2c′·CH3COOH in
Colo205, Colo320, and MRC-5 Cell Lines after 72 h of
Exposure
IC50 (μM) Colo205 Colo320 MRC-5
HL1 >100 6.32 ± 0.49 >100
HL2 >100 >100 >100
HL3 48.2 ± 6.8 >100 >100
Cu(HL1)Cl2 2.08 ± 0.12 2.21 ± 0.18 3.13 ± 0.17
[Cu(L2)Cl] 0.181 ± 0.039 0.159 ± 0.009 0.276 ± 0.049
Cu(HL3)Cl2 26.6 ± 1.6 27.6 ± 1.6 >100
HL1a′ >25 >25 >25
HL1a″ >25 >25 >25
HL2c′·CH3COOH 2.733 ± 0.059 0.188 ± 0.041 2.15 ± 0.10
CuCl2 19.7
a 20.0a 24.5a
triapine 3.34 ± 0.12 4.21 ± 0.46 10.2 ± 1.3
doxorubicin 3.28a 3.12a 5.19a
aData are taken from ref 77.
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impact of the copper(II) coordination on the HL2 inhibitory
activity is quite obvious, when the ability to quench the tyrosyl
radical by HL2 is compared to that of 2′. Interestingly, the two-
electron oxidized product of HL2, namely, HL2c′·CH3COOH,
is as potent as HL3 in tyrosyl radical reduction.
The ability of HL1−HL3 and 1, 2′, and 3 to quench the
tyrosyl radical correlates well with their first anodic redox
potentials (0.82−0.88 V vs NHE) and (0.68−0.70 V vs NHE),
respectively, which are well-compared with redox potential of
hydroxyurea (+0.724 V),83 which reduced the tyrosyl radical in
the R2 protein with an estimated redox potential of 1.0 ± 0.1 V
vs NHE.36 Note, however, that hydroxyurea, a well-known
inhibitor of RNR and an anticancer drug,84 is a small molecule
able to enter the hydrophobic R2 protein pocket, where the
tyrosyl radical is buried. Finally, the two- and four-electron
oxidized products of HL1, namely, HL1a′ and HL1a″, do not
have an effect on the tyrosyl radical in the absence of DTT
and, interestingly, cause an increase in the radical content in
the presence of DTT (Figure S15).
Previously it has been shown that the radical content in mR2
may be slightly increased in the presence of DTT, as the result
of the so-called radical reconstitution reaction,17,85 in which the
DTT−reduced diiron center in the reaction with molecular
oxygen is spontaneously oxidized through a series of
intermediate states, generating the active Fe(III)-O2−-Fe-
(III)/Tyr· cofactor. However, the radical increase caused by
HL1a′ and HL1a″ (in reducing conditions) is much greater
than that observed for DTT, providing evidence that the
formation of the active iron/radical site in mR2 is more
efficient when the DTT−reduced form of mR2 is oxidized by
HL1a′ or HL1a″, than by molecular oxygen only.
Consistent with enzyme inhibition studies, which revealed a
potent inhibition of mR2 RNR, compounds HL1, 1, and 2′
were found to increase the population of the S-phase in SW480
cells.
Cell Cycle Arrest. The perturbation effects of 10 μM HL1,
1, and 2′ on the cell cycle progression of SW480 cells when
compared to negative control are shown in Figure 16 and
Table S9, while the effects of 0, 1.0, and 10 μM are presented
in Figure S16. It can be noted that the population of S-phase
cells increased after an incubation with HL1 (37.1%), complex
1 (44.0), and 2′ (46.5) compared with the negative control
(29.8%). Gemcitabine (GC), a positive control, showed a
canonical G1/S-phase arrest at the concentration of 0.01 μM
with 26.8% of cells in the G1 phase and 62.3% of cells in the S
phase compared to the negative control with 49.1% of cells in
the G1 phase and 29.8% of cells in the S phase (Figure S17).
An increase in the population of the S-phase cells by ca. 20%
Figure 14. Quantification of apoptosis in Colo320 cells treated with HL1 and 2′ and M627 and cisplatin (as positive controls) using the Annexin-
V/PI double staining assay. Colo320 cells were treated at the indicated concentration of the drugs. The dual parametric dot plots that combine the
Annexin-V (FL1) and PI (FL3) fluorescence show the viable cell population in the lower-left quadrant Annexin-V−/PI− (Q4), the early apoptotic
cells in the lower-right quadrant Annexin-V+/PI− (Q3), and the late apoptotic and necrotic cells in the upper-right quadrant Annexin-V+/PI+
(Q2). (Number of cells counted: 23 193 (M627), 20 262 (cisplatin), 33 193 (HL1), and 19 312 (2′)).
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has been reported for a series of triapine analogues at
concentrations from 0.25 to 5.0 μM.80 The S-phase arrest is
characteristic for cells treated with triapine.81
These data indicate that there is a correlation between the
ability of the compounds tested to inhibit R2 RNR and their
ability to induce an S-phase arrest. Nevertheless, the inhibition
of RNR does not appear to be the main mechanism underlying
the antiproliferative activity of both TSCs studied herein and
their copper(II) complexes.
ROS Generation. Since metal-free TSCs that enter the
cells or are released from copper(I) complexes generated by a
reduction of their copper(II) counterparts can react in the cells
with iron(II), the redox activity of the [FeII(L1)2] complex,
prepared by the reaction of an anoxic aqueous solution of
FeSO4·7H2O with a DMSO solution of HL
1 at a 1:2 molar
ratio, was investigated by EPR spin-trapping experiments. To
investigate whether this ferrous complex is able to generate
ROS in the aqueous environment by a Fenton reaction, which
is supposed to quench the tyrosyl radical of the mR2 enzyme,
hydrogen peroxide was added into the system in the presence
of 5,5-dimethyl-1-pyrroline N-oxide (DMPO) as the spin-
trapping agent. A four-line EPR signal characteristic for the ·
OH-DMPO spin adduct was observed (Figure 17, black trace,
EPR signal marked with circles).
Additionally a ·DMPO-OCH3 spin adduct can be seen in the
corresponding EPR spectrum as a consequence of the reaction
of hydroxyl radicals with the DMSO solvent forming methyl
radicals, which react with molecular oxygen resulting in the
generation of peroxomethyl radicals serving as a source of
•DMPO−OCH3 spin adducts (Figure 17, black trace, EPR
signal marked with squares).82 Only a trace amount of carbon-
centered radicals was detected for Fe(II)/HL1/DMPO in
H2O−DMSO in the absence of H2O2 (Figure 17, blue and red
traces, EPR signal marked with stars). In this case DMSO acts
as a HO· scavenger, generating reactive carbon-centered
radicals, which are trapped by DMPO. It is important to
mention that no radicals were formed in the system of HL1/
H2O2/DMPO/H2O−DMSO (not shown), which indicates the
crucial role of the Fe(II) complex for ROS generation.
Consequently complex [FeII(L1)2] is redox-active in the
Fenton reaction indicating the important role of the HL1
ligand for the observed antiproliferative activity against cancer
cell lines and its ability to quench the tyrosyl radical in the
mR2 protein. A direct reduction of the tyrosyl radical by
iron(II) complexes with reported TSCs can also not be
excluded.16
■ CONCLUSIONS
New triapine analogues bearing a redox-active p-amino-
phenolic moiety and their copper(II) complexes have been
synthesized and characterized by spectroelectrochemical and
analytical techniques, which confirmed the noninnocent
identity of the latter. The crystal structures of TSCs HL1−
HL3 and complexes [Cu(L1−3)Cl] were studied by SC-XRD
revealing the tridentate (N,N,S) coordination mode of the
ligands. The presence of E and Z isomers of HL1−HL3 with a
predominance of the first one in DMSO has been disclosed by
1D and 2D NMR spectroscopy. These data along with DFT
calculations on the model compound 2-formylpyridine TSC
indicate that the Z/E isomerization involves an inversion at the
aldimine nitrogen atom, rather than a tautomeric shift of the
thioamide N2H proton to the pyridine nitrogen, followed by a
rotation around the C−N1 bond as suggested previously.44
The relatively high Gibbs free energy barrier (∼35.3 kcal/mol)
for the Z/E conversion rules out the possibility of an
isomerization at room temperature, in agreement with time-
dependent NMR data.
A two-electron oxidative dehydrogenation of HL1 by a
reaction with 1 equiv of DDQ afforded the new species HL1a′
containing a thiadiazole five-membered ring formed via a
nucleophilic attack of a thione sulfur atom on an aldimine
carbon atom. This is supported by frontier molecular orbitals
(MOs) with the HOMO and LUMO located at opposite parts
of the molecule of HL1. When 2 equiv of DDQ were used, a
further two-electron oxidation coupled with a two-proton loss
occurred at the 3,5-dimethyl-4-aminophenolic moiety to give
the 3,5-dimethyl-1,4-benzoquinone imine unit in HL1a″. Also
note that the coordinated ligand HL1 is able to form a thiazole
five-membered ring in 4 via a sulfur attack on the carbon atom
in position 2 or 6 of the 3,5-dimethyl-4-aminophenolic moiety.
The arylated sulfur atom has lost the competition in binding to
copper(II) for an end nitrogen atom due to the reduction of
the electron-donating ability of the sulfur atom. The oxidation
of HL2 with PBQ in a 1:1 molar ratio furnished the two-
electron oxidative cyclization product HL2b and the diphenolic
species HL2e. A tentative mechanism of their formation is
proposed. The pathway to HL2e implies the formation of the 4-
isothiocyanato-2,6-dimethylphenol intermediate. Treatments
of HL2 with 1 and 2 equiv of PIDA afforded the two-electron
oxidation product HL2c′ and the four-electron oxidation
product HL2c″, respectively. In contrast to HL1−HL3, the Z/
E isomerization was observed at room temperature for HL2c′.
The isolation and investigation of oxidation products of new
TSCs was of interest also from the point of view of collecting
spectroscopic data that might be useful for an eventual analysis
of metabolites, which can be generated in vivo from the
corresponding TSCs and their copper(II) complexes.
Solution equilibrium studies performed by UV−vis spec-
trophotometry revealed the acidic pKa values (3.01−3.95) of
the pyridinium nitrogen and pKa values greater than or equal
Figure 15. Tyrosyl radical reduction kinetics in mouse R2 RNR
protein by TSCs HL1, HL2, HL3, and their corresponding copper
complexes 1, 2′, and 3 as well as by the two-electron oxidized product
of HL2 (HL2c′·CH3COOH), in the presence of an external reductant,
measured at 30 K by EPR spectroscopy and compared to triapine.
The samples contained 20 μM mR2 in 50 mM HEPES buffer, pH
7.60/100 mM KCl, 20 μM compound in 1% (v/v) DMSO/H2O, and
2 mM DTT.
Inorganic Chemistry pubs.acs.org/IC Article
https://doi.org/10.1021/acs.inorgchem.1c01275
Inorg. Chem. XXXX, XXX, XXX−XXX
R
to 10.55 for the hydrazinic-NNH and phenolic (PhOH)
moiety of the metal-free ligands. The latter are neutral and
stable at a physiological pH. However, they become air-
sensitive upon deprotonation of the OH group in the basic pH
range. The formation of high-stability monoligand copper(II)
complexes was found in different protonation states in




are probable. The complexes with a (Npyridine,N,S
−)(H2O)
coordination predominate in a wide pH range including pH
7.4. Conditional stability constants determined for the
[Cu(L1)]+ and [Cu(L3)]+ complexes by an EDTA UV−vis
spectrophotometric competition experiment show the some-
what higher stability of the [Cu(L3)]+ complex. The
attachment of a phenolic moiety undoubtedly increases the
lipophilicity of new Schiff bases and copper(II) complexes
when compared to triapine and its copper(II) complex. The
new complexes can be reduced by glutathione, the most
abundant low molecular mass reducing agent in a cell, in a
reversible redox reaction. According to the electrochemical
studies complexes 1, 2′, and 3 can undergo a redox process in a
Figure 16. Flow cytometry analysis for a cell cycle distribution of SW480 cells induced by TSC HL1 (B) and complexes 1 (C) and 2′ (D) at the
concentration of 10 μM for 24 h compared to the negative control (DMSO) (A).
Figure 17. Experimental EPR spectra of Fe(II)/HL1/DMPO/H2O2
in 5% (v/v) H2O−DMSO (black line), in the system of Fe(II)/HL1/
DMPO in 5% (v/v) H2O−DMSO (blue line), and in 30% (v/v)
H2O−DMSO (red line). Initial concentrations: c(HL1) = 0.2 mM,
c(FeSO4·7H2O) = 0.1 mM, c(DMPO) = 20 mM, c(H2O2) = 10 mM.
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biologically accessible window (−0.4 to +0.8 V vs Fc+/Fc).
These findings suggest a possible role of the redox properties
of the copper(II) complexes in their biological activity.
The metal-free ligands and several oxidized products showed
no or only a moderate cytotoxicity against doxorubicin-
sensitive Colo205 and the multidrug-resistant Colo320 human
colonic adenocarcinoma cell lines. Their copper(II) complexes
revealed a high cytotoxic potency when compared to that of
the corresponding metal-free ligands. [Cu(L2)Cl] showed the
highest cytotoxic activity with IC50 values in the low
micromolar concentration range and induced apoptosis,
while Cu(HL3)Cl2 has the highest selectivity for cancer cells
over the normal fibroblast MRC-5 cells. The highest
antiproliferative activity of [Cu(L2)Cl] is likely due to the
more negative reduction potential when compared to those of
1 and 3 and low reduction rate in reaction with GSH.36 In
addition, HL1−HL3 and their copper(II) complexes were
found to efficiently quench the tyrosyl radical in mR2 RNR in
the presence of DTT as an external reductant and increase the
population of S-phase cells. The capacity of HL1 to destroy the
tyrosyl radical is almost identical with that of triapine, which is
by the factor of 1000 a more potent R2 RNR inhibitor than
hydroxyurea, a known clinical drug.17 Thus, the copper(II)
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